Skip to main content


The Genoma España Foundation has launched a line of credit for biotechnological companies searching for second rounds of investment as  complementary expansion to additional private funds (venture capital or investment capital), with a maximum of €450,000. Parallel, it has launched a second line of credit to facilitate patent licensing or shareholdings acquisition in High Tech Startups coming from projects funded by the Genoma España technological portfolio, until a maximum amount of €450,000.

The call is open while budget lasts or until 30th June 2012. In total, €4M will be allocated to this action by Genome.

Related news: Genoma España, ICEX, CDTI and Asebio create USA Landing program (14/12/2011)

Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.